Search

Endocrine Testing Market

Endocrine Testing Market Size by Test (Estradiol(E2), Luteinizing Hormone (LH), Dehydroepiandrosterone sulfate (DHEAS), Cortisol, Follicle-stimulating hormone(FSH), Prolactin Human Chorionic Ganadotropin (hCG) , Testosterone, Thyroid Stimulating Hormone(TSH) , Insulin, Progesterone ),Diagnostic Technology (Immunoassay, Clinical Chemistry, Monoclonal & Polyclonal Antibody, Tandem Mass Spectroscopy, ), End User, Regions, Global Industry Analysis, Share, Growth, Trends, and Forecast 2021 to 2028

Base Year: 2020 Historical Data: 2018-19
  • Report ID: TBI-12529
  • Published Date: Oct, 2021
  • Pages: 219
  • Category: Healthcare
  • Format: PDF
Buy @ $4700.00 Request Sample PDF

Global endocrine testing market is expected to reach USD 17.84 billion by 2028, at a CAGR of 6% from 2021 to 2028. Global endocrine testing market is witnessing a considerable growth owing to the rising number of patients suffering from diabetes.

Market Overview:

Endocrine System is an integrated network consisting of many glands in the body. Endocrine system, along with the nervous system together control and channelize the functionality of the body. The hormone secreted by the glands into the bloodstream is used as a chemical messenger, which, with the help of the nervous system, carry out the functionality of the body. The endocrine system has many glands, in different parts of the body, they secret glands directly into the blood and not into the duct system, and hence endocrine glands are called ductless glands. The study of the diseases in the endocrine system is called endocrinology. These diseases is due to many reasons which include secretion level of hormone, type of action done by hormone and the problems in secreting hormones etc. The kind of hectic and sophisticated life of the people these days are inviting many illness, which include various disease due to endocrine disorders such as infertility, diabetes etc. This is driving the endocrine testing market. Obesity is also one of the factors driving the endocrine testing market. The Obesity also slowly led to diabetes. The unhealthy lifestyle and food habits are leading to such kind of diseases, and this trend is rather increasing, so the endocrine testing market seems to grow in the coming years. However, people with rising per capita income in developed and developing countries want to live a quality lifestyle, which make them conscious about their health and are indulging body work out in their daily lifestyle. They are also realizing the need for full body checkup and the endocrine testing periodically, which are some of the factors driving the market. But the high cost of some of the most advanced endocrine testing technologies are acting as a restraint for the market, as this remains unaffordable to the majority of the population in the developing countries. Also, the educational backwardness in the underdeveloped countries are leading to a lack of health awareness, which is also acting as a restraint for the market, especially in the backward region.

Get an overview of this study by requesting a free sample

Market Dynamics

Drivers:
  • Rising number of patients suffering from diabetes

As mentioned the hectic lifestyle and unhealthy food habits are leading to a rising number of patients suffering from diabetes. Moreover, the increasing geriatric population in the developed economies would also propel this market. Insulin is also playing a crucial role in the post-diagnostic management of diabetes. This has made it important for endocrine testing market. The sedentary lifestyle in the developing economies is the major reason for the rising of the diabetic population. But the awareness about the health in the developing economies would drive the market.

  • Rising prevalence of obesity

The rising prevalence of obesity is driving the endocrine testing market. The hormonal imbalance would led to obesity. This imbalance in the secretion of the hormone could be because of unhealthy food habits and lifestyle. Less physical work in daily life and sedentary lifestyle in this modern world are responsible for the prevalence of obesity, which could ultimately lead to diabetes. So these all factors are driving the endocrine testing market.

Restraints:
  • High cost associated with Endocrine Testing treatment

Some of the advanced endocrine testing, technologies are very expensive. This is a major restraint for the endocrine testing market. These advanced technologies are very handy in the diagnosis for many diseases, but the problem would be that it will be unaffordable for the majority of the population and it doesn't seems to change in the near future. The educational backwardness in the underdeveloped countries are leading to a lack of health awareness, which is also acting as a restraint for the market, especially in the backward region.

Opportunities:
  • Rising incidences of endocrine disorders and increasing health care awareness

The increasing disposable income in developing economies along with better infrastructure in terms of transport, healthcare facility etc. act as better opportunities for the growth of this market. The surge in disposable income of the people have now given them access for the quality of life, better facilities and also quality products and services. People are now much more aware of their health. Moreover, in developing economies, the healthcare infrastructure has also gone up. With more access of quality things, people are looking for better healthcare facilities, which created the demand for better facilities and services. Thou the cost is high, but with the increase in disposable income, people have now access for those quality costly healthcare treatment and services

Segmentation Analysis:

The global Endocrine Testing market has been segmented based on test, diagnostic technology, end user and regions.

  • Test segment include Follicle-stimulating hormone(FSH), Human Chorionic Gonadotropin (hCG), Thyroid Stimulating Hormone(TSH), Dehydroepiandrosterone sulfate (DHEAS), Prolactin, Progesterone, Insulin, Cortisol, Testosterone, Estradiol(E2) and Luteinizing Hormone (LH). The Thyroid-stimulating hormone (TSH) segment held the largest market share of over 12.23% in 2020. This is due to the rising cases of TSH-related disorders and the growing awareness related to the connection between the secretion of improper thyroid hormones levels and cardiovascular disorders. Insulin test is looking promising for the fastest growth in the forecasting period. Insulin plays an important segment in the endocrine testing market. Also, the surge in the diabetic population and the awareness and familiarity about this kind of diagnosis are the main reasons.
  • The Diagnostic Technology segment includes Immunoassay, Clinical Chemistry, Monoclonal and Polyclonal Antibody and Tandem Mass Spectroscopy. Tandem Mass Spectroscopy segment accounted for the largest market share in 2020 of around 31.28%. This is due to the growing use of tandem mass spectrometry. Sensor technology seems to show the fastest growth in the coming years. This is because the biosensors have become very common in a glucose monitoring system. Common people use this system to check the glucose level for diabetes. This has become a household product now, and people use to check for diabetes periodically.
  • The End User segment includes Hospitals, physician’s offices, health care centers, and commercial laboratories. Hospitals accounted for the largest market share in 2020 of around 34.15%. Most people still prefer hospitals for the check-ups and the test. This is because hospitals are perceived as the institution to provide better service and have better infrastructure. The same reason will also make this segment to dominate in the forecasting period.
Regional Segmentation Analysis:

The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and the Middle East and Africa. North America is dominating the market by having the largest market share of 40.8% in 2020.

  • North America is having the largest market share because the healthcare infrastructure is better in this region and having a well-developed hospitals at all levels be it primary, secondary or tertiary level. Also, the government funding and the reimbursement policy are driving the endocrine testing market in this region.
  • Asia Pacific seems to witness a good CAGR of 8.1% in the forecasting period. This is due to the increasing expenditure in R&D by government and private agencies for better diagnostic center and to provide better facilities. Also, the government in the developing economies like India, China, are investing for better healthcare infrastructure. These factors would further boost the market in the region.

The North America Endocrine Testing Market Share in 2020- 40.8%

 

www.thebrainyinsights.com

Check the geographical analysis of this market by requesting a free sample

Competitive Analysis:

The key players are now concentrating on implementing strategies such as adopting new technology, product innovations, mergers & acquisitions, joint venture, alliances and partnerships to improve their market position in the global endocrine testing industry.

For instance, in October 2019, LabCorp acquired lab testing business of Indiana’s South Bend Medical Foundation(SBMF). This acquisition would help the organization in expanding its business in the mid-west region of the US.

For instance, in January 2020, Quest Diagnostics collaborated with Memorial Hermann Health System to provide better and high-value laboratory services in the Greater Houston region.

List of Key Market Players:

  • Quest Diagnostics
  • Thermo Fisher Scientific
  • Siemens Healthcare
  • Ortho Clinical Diagnostics
  • bioMerieux
  • Agilent Technologies
  • Abbott Laboratories
  • Thermo Fisher Scientific
  • Beckman Coulter, Inc
  • BioRad Laboratories
  • AB Sciex
  • F-Hoffmann La Roche AG,
  • LabCorp

Key Target Audience

  • Hospitals
  • Clinics
  • Government Authorities
  • Research Organization
  • Research and Consulting Firms

Report Description:

  • Global endocrine testing Market, Industry Analysis, Trends, Analysis and Forecast, 2021 to 2028 is a forthcoming/imminent research report which is to be published by The Brainy Insights.
  • 2020 is considered as the base year of the report. 2018 and 2019 are considered as the historic years and 2021 to 2028 are the forecast years. The global endocrine testing market is based on revenue (USD Million/Billion), volume and price. The report incorporates the market study on the basis of revenue, and volume. The study covers the market share revenue/market share/volume for each of the segments, regions and countries catering to global Endocrine Testing market. The regions analyzed for the market are Europe, Asia Pacific, North America, South America and Middle East & Africa. Furthermore, the regions are further analyzed at the country level.
  • The report encompasses with the relative data & information, which have been validated by the leading industry professionals and experts all across the globe. The research report also delivers an outline of the attractiveness of test, diagnostic technology, end user and regions which are deduced and formulated on the basis of their growth rate (CAGR), market size, and attractiveness by analyzing the present and future prospects to fathom market growth and development in future.
  • The report illustrates the detailed (both quantitative and qualitative) analysis of historical data, revenues, key developments, along with the crucial strategies adopted by key organizations catering to global endocrine testing market.  This offers vital and in depth insights in order to depict the overall market scenario.
  • The report offers the detailed study for the company profiles of key organizations operating in the global endocrine testing market and a comparative assessment based on their product offering, business overviews, geographic presence, business strategies, segment market share, product development & innovations, recent developments, joint venture, partnerships, mergers & acquisitions, strategic alliances, SWOT analysis, and key financial information. This helps in evaluating the overall competition present in the market scenario. 
  • The report provides an elaborative assessment of the porter’s five forces analysis coupled with SWOT analysis so as to provide business related data and information’s. Porter’s five forces model is analyzed to understand the overall competitive scenario that is prevailing in the market. Additionally, the SWOT analysis identifies both the positive and negative attributes of the market development which influences the company growth and development in order to sustain and survive in the long run.
  • Along with that, the report also focuses on the market related driving factors, growth limitations (restraints), potential industry opportunities, significant trends and development which acts as a key potential for the investors. 
  • Potential growth prospects along with the penetration rate analysis of the products (market related i.e., global endocrine testing market) is covered in order to comprehend the adoption rate and evaluate the market size.

Frequesntly Asked Questions

As per The Brainy Insights, the size of the endocrine testing market was valued at USD 10.33 billion in 2020 and is anticipated to reach USD 17.84 billion by 2028.

Global endocrine testing market is growing at a CAGR of 6% during the forecast period 2021-2028.

The global endocrine testing market has been segmented based on test, diagnostic technology, end user and regions. Tandem mass spectroscopy segment accounted for the largest market share.

The North America region emerged as the largest market for the endocrine testing.

Rising number of patients suffering from diabetes is the key driving factor for the endocrine testing market.

High cost associated with endocrine testing treatment could hamper the market growth.

Rising incidences of endocrine disorders and increasing health care awareness will provide huge opportunities to the market.

Key players are Quest Diagnostics, Thermo Fisher Scientific, Siemens Healthcare, Ortho Clinical Diagnostics, bioMerieux, Agilent Technologies.

Get Your Report Customized

  • Further segmentation of the market on the basis of type, application, end use, product, technology, method, process and any other segment depending on the market
  • Segmentation on the basis of any specific country or region
  • Any segment can be classified on the basis of application
  • Application segment can be further divided on the basis of companies
  • The companies profiled are not limited, we can incorporate additional companies of your choice
  • We can split the company market share on the basis of product, application and region
  • Report can be prepared for any specific country/region/segment
  • Customers can be added on the basis of regions and countries
Request for Customization

1. Introduction
    1.1. Objectives of the Study
    1.2. Market Definition
    1.3. Research Scope
    1.4. Currency
    1.5. Key Target Audience

2. Research Methodology and Assumptions

3. Executive Summary

4. Premium Insights
    4.1. Porter’s Five Forces Analysis
    4.2. Value Chain Analysis
    4.3. Top Investment Pockets
          4.3.1. Market Attractiveness Analysis By Test
          4.3.2. Market Attractiveness Analysis By Diagnostic Technology
          4.3.3. Market Attractiveness Analysis By End User
          4.3.4. Market Attractiveness Analysis By Region
    4.4. Industry Trends

5. Market Dynamics
    5.1. Market Evaluation
    5.2. Drivers
          5.2.1. Rising number of patients suffering from diabetes
          5.2.2. Rising prevalence of obesity
    5.3. Restraints
          5.3.1. High cost associated with Endocrine Testing treatment
    5.4. Opportunities
          5.4.1. Rising incidences of endocrine disorders and increasing health care awareness

6. Global Endocrine Testing Market Analysis and Forecast, By Test
    6.1. Segment Overview
    6.2. Follicle stimulating hormone(FSH)
    6.3. Human Chorionic Gonadotropin (hCG)
    6.4. Thyroid Stimulating Hormone(TSH)
    6.5. Dehydroepiandrosterone sulfate (DHEAS)
    6.6. Prolactin
    6.7. Progesterone
    6.8. Insulin
    6.9. Cortisol
    6.10. Testosterone
    6.11. Estradiol(E2)
    6.12. Luteinizing Hormone (LH)

7. Global Endocrine Testing Market Analysis and Forecast, By Diagnostic Technology
    7.1. Segment Overview
    7.2. Immunoassay
    7.3. Clinical Chemistry
    7.4. Monoclonal and Polyclonal Antibody
    7.5. Tandem Mass Spectroscopy

8. Global Endocrine Testing Market Analysis and Forecast, By End User
    8.1. Segment Overview
    8.2. Hospitals
    8.3. Physicians Offices
    8.4. Health Care Centers
    8.5. Commercial Laboratories

9. Global Endocrine Testing MarketAnalysis and Forecast, By Regional Analysis
    9.1. Segment Overview
    9.2. North America
          9.2.1. U.S.
          9.2.2. Canada
          9.2.3. Mexico
    9.3. Europe
          9.3.1. Germany
          9.3.2. France
          9.3.3. U.K.
          9.3.4. Italy
          9.3.5. Spain
    9.4. Asia-Pacific
          9.4.1. Japan
          9.4.2. China
          9.4.3. India
    9.5. South America
          9.5.1. Brazil
    9.6. Middle East and Africa
          9.6.1. UAE
          9.6.2. South Africa

10. Global Endocrine Testing Market-Competitive Landscape
    10.1. Overview
    10.2. Market Share of Key Players in GlobalEndocrine Testing Market
          10.2.1. Global Company Market Share
          10.2.2. North America Company Market Share
          10.2.3. Europe Company Market Share
          10.2.4. APAC Company Market Share
    10.3. Competitive Situations and Trends
          10.3.1. Product Launches and Developments
          10.3.2. Partnerships, Collaborations, and Agreements
          10.3.3. Mergers & Acquisitions
          10.3.4. Expansions

11. Company Profiles
    11.1. Quest Diagnostics
          11.1.1. Business Overview
          11.1.2. Company Snapshot
          11.1.3. Company Market Share Analysis
          11.1.4. Company Product Portfolio
          11.1.5. Recent Developments
          11.1.6. SWOT Analysis
    11.2. Thermo Fisher Scientific
          11.2.1. Business Overview
          11.2.2. Company Snapshot
          11.2.3. Company Market Share Analysis
          11.2.4. Company Product Portfolio
          11.2.5. Recent Developments
          11.2.6. SWOT Analysis
    11.3. Siemens Healthcare
          11.3.1. Business Overview
          11.3.2. Company Snapshot
          11.3.3. Company Market Share Analysis
          11.3.4. Company Product Portfolio
          11.3.5. Recent Developments
          11.3.6. SWOT Analysis
    11.4. Ortho Clinical Diagnostics
          11.4.1. Business Overview
          11.4.2. Company Snapshot
          11.4.3. Company Market Share Analysis
          11.4.4. Company Product Portfolio
          11.4.5. Recent Developments
          11.4.6. SWOT Analysis
    11.5. bioMerieux
          11.5.1. Business Overview
          11.5.2. Company Snapshot
          11.5.3. Company Market Share Analysis
          11.5.4. Company Product Portfolio
          11.5.5. Recent Developments
          11.5.6. SWOT Analysis
    11.6. Agilent Technologies
          11.6.1. Business Overview
          11.6.2. Company Snapshot
          11.6.3. Company Market Share Analysis
          11.6.4. Company Product Portfolio
          11.6.5. Recent Developments
          11.6.6. SWOT Analysis
    11.7. Abbott Laboratories
          11.7.1. Business Overview
          11.7.2. Company Snapshot
          11.7.3. Company Market Share Analysis
          11.7.4. Company Product Portfolio
          11.7.5. Recent Developments
          11.7.6. SWOT Analysis
    11.8. Thermo Fisher Scientific
          11.8.1. Business Overview
          11.8.2. Company Snapshot
          11.8.3. Company Market Share Analysis
          11.8.4. Company Product Portfolio
          11.8.5. Recent Developments
          11.8.6. SWOT Analysis
    11.9. Beckman Coulter, Inc
          11.9.1. Business Overview
          11.9.2. Company Snapshot
          11.9.3. Company Market Share Analysis
          11.9.4. Company Product Portfolio
          11.9.5. Recent Developments
          11.9.6. SWOT Analysis
    11.10. BioRad Laboratories
          11.10.1. Business Overview
          11.10.2. Company Snapshot
          11.10.3. Company Market Share Analysis
          11.10.4. Company Product Portfolio
          11.10.5. Recent Developments
          11.10.6. SWOT Analysis
    11.11. AB Sciex
          11.11.1. Business Overview
          11.11.2. Company Snapshot
          11.11.3. Company Market Share Analysis
          11.11.4. Company Product Portfolio
          11.11.5. Recent Developments
          11.11.6. SWOT Analysis
    11.12. F-Hoffmann La Roche AG
          11.12.1. Business Overview
          11.12.2. Company Snapshot
          11.12.3. Company Market Share Analysis
          11.12.4. Company Product Portfolio
          11.12.5. Recent Developments
          11.12.6. SWOT Analysis
    11.13. LabCorp
          11.13.1. Business Overview
          11.13.2. Company Snapshot
          11.13.3. Company Market Share Analysis
          11.13.4. Company Product Portfolio
          11.13.5. Recent Developments
          11.13.6. SWOT Analysis
 

List of Table

1. Global Endocrine Testing Market, By Test, 2018-2028 (USD Billion)

2. Global Follicle stimulating hormone(FSH)Endocrine Testing Market, By Region, 2018-2028 (USD Billion)

3. Global Human Chorionic Gonadotropin (hCG)Endocrine Testing Market, By Region, 2018-2028 (USD Billion)

4. Global Thyroid Stimulating Hormone(TSH)Endocrine Testing Market, By Region, 2018-2028 (USD Billion)

5. Global Dehydroepiandrosterone sulfate (DHEAS)Endocrine Testing Market, By Region, 2018-2028 (USD Billion)

6. Global Prolactin Endocrine Testing Market, By Region, 2018-2028 (USD Billion)

7. Global Progesterone Endocrine Testing Market, By Region, 2018-2028 (USD Billion)

8. Global Insulin Endocrine Testing Market, By Region, 2018-2028 (USD Billion)

9. Global Cortisol Endocrine Testing Market, By Region, 2018-2028 (USD Billion)

10. Global Testosterone Endocrine Testing Market, By Region, 2018-2028 (USD Billion)

11. Global Estradiol(E2) Endocrine Testing Market, By Region, 2018-2028 (USD Billion)

12. Global Luteinizing Hormone (LH) Endocrine Testing Market, By Region, 2018-2028 (USD Billion)

13. Global Endocrine Testing Market, By Diagnostic Technology, 2018-2028 (USD Billion)

14. Global Immunoassay, Endocrine Testing Market, By Region, 2018-2028 (USD Billion)

15. Global Clinical Chemistry, Endocrine Testing Market, By Region, 2018-2028 (USD Billion)

16. Global Monoclonal and Polyclonal Antibody, Endocrine Testing Market, By Region, 2018-2028 (USD Billion)

17. Global Tandem Mass Spectroscopy, Endocrine Testing Market, By Region, 2018-2028 (USD Billion)

18. Global Endocrine Testing Market, By End User, 2018-2028 (USD Billion)

19. Global Hospitals, Endocrine Testing Market, By Region, 2018-2028 (USD Billion)

20. Global Physicians Offices, Endocrine Testing Market, By Region, 2018-2028 (USD Billion)

21. Global Health Care Centers, Endocrine Testing Market, By Region, 2018-2028 (USD Billion)

22. Global Commercial Laboratories, Endocrine Testing Market, By Region, 2018-2028 (USD Billion)

23. Global Endocrine Testing Market, By Region, 2018-2028 (USD Billion)

24. Global Endocrine Testing Market, By North America, 2018-2028 (USD Billion)

25. North America Endocrine Testing Market, By Test, 2018-2028 (USD Billion)

26. North America Endocrine Testing Market, By Diagnostic Technology, 2018-2028 (USD Billion)

27. North America Endocrine Testing Market, By End User, 2018-2028 (USD Billion)

28. U.S. Endocrine Testing Market, By Test, 2018-2028 (USD Billion)

29. U.S. Endocrine Testing Market, By Diagnostic Technology, 2018-2028 (USD Billion)

30. U.S. Endocrine Testing Market, By End User, 2018-2028 (USD Billion)

31. Canada Endocrine Testing Market, By Test, 2018-2028 (USD Billion)

32. Canada Endocrine Testing Market, By Diagnostic Technology, 2018-2028 (USD Billion)

33. Canada Endocrine Testing Market, By End User, 2018-2028 (USD Billion)

34. Mexico Endocrine Testing Market, By Test, 2018-2028 (USD Billion)

35. Mexico Endocrine Testing Market, By Diagnostic Technology, 2018-2028 (USD Billion)

36. Mexico Endocrine Testing Market, By End User, 2018-2028 (USD Billion)

37. Europe Endocrine Testing Market, By Test, 2018-2028 (USD Billion)

38. Europe Endocrine Testing Market, By Diagnostic Technology, 2018-2028 (USD Billion)

39. Europe Endocrine Testing Market, By End User, 2018-2028 (USD Billion)

40. Germany Endocrine Testing Market, By Test, 2018-2028 (USD Billion)

41. Germany Endocrine Testing Market, By Diagnostic Technology, 2018-2028 (USD Billion)

42. Germany Endocrine Testing Market, By End User, 2018-2028 (USD Billion)

43. France Endocrine Testing Market, By Test, 2018-2028 (USD Billion)

44. France Endocrine Testing Market, By Diagnostic Technology, 2018-2028 (USD Billion)

45. France Endocrine Testing Market, By End User, 2018-2028 (USD Billion)

46. U.K. Endocrine Testing Market, By Test, 2018-2028 (USD Billion)

47. U.K. Endocrine Testing Market, By Diagnostic Technology, 2018-2028 (USD Billion)

48. U.K. Endocrine Testing Market, By End User, 2018-2028 (USD Billion)

49. Italy Endocrine Testing Market, By Test, 2018-2028 (USD Billion)

50. Italy Endocrine Testing Market, By Diagnostic Technology, 2018-2028 (USD Billion)

51. ItalyEndocrine Testing Market, By End User, 2018-2028 (USD Billion)

52. Spain Endocrine Testing Market, By Test, 2018-2028 (USD Billion)

53. Spain Endocrine Testing Market, By Diagnostic Technology, 2018-2028 (USD Billion)

54. Spain Endocrine Testing Market, By End User, 2018-2028 (USD Billion)

55. Asia Pacific Endocrine Testing Market, By Test, 2018-2028 (USD Billion)

56. Asia Pacific Endocrine Testing Market, By Diagnostic Technology, 2018-2028 (USD Billion)

57. Asia Pacific Endocrine Testing Market, By End User, 2018-2028 (USD Billion)

58. Japan Endocrine Testing Market, By Test, 2018-2028 (USD Billion)

59. Japan Endocrine Testing Market, By Diagnostic Technology, 2018-2028 (USD Billion)

60. Japan Endocrine Testing Market, By End User, 2018-2028 (USD Billion)

61. China Endocrine Testing Market, By Test, 2018-2028 (USD Billion)

62. China Endocrine Testing Market, By Diagnostic Technology, 2018-2028 (USD Billion)

63. China Endocrine Testing Market, By End User, 2018-2028 (USD Billion)

64. India Endocrine Testing Market, By Test, 2018-2028 (USD Billion)

65. India Endocrine Testing Market, By Diagnostic Technology, 2018-2028 (USD Billion)

66. India Endocrine Testing Market, By End User, 2018-2028 (USD Billion)

67. South America Endocrine Testing Market, By Test, 2018-2028 (USD Billion)

68. South America Endocrine Testing Market, By Diagnostic Technology, 2018-2028 (USD Billion)

69. South America Endocrine Testing Market, By End User, 2018-2028 (USD Billion)

70. Brazil Endocrine Testing Market, By Test, 2018-2028 (USD Billion)

71. Brazil Endocrine Testing Market, By Diagnostic Technology, 2018-2028 (USD Billion)

72. Brazil Endocrine Testing Market, By End User, 2018-2028 (USD Billion)

73. Middle East and Africa Endocrine Testing Market, By Test, 2018-2028 (USD Billion)

74. Middle East and Africa Endocrine Testing Market, By Diagnostic Technology, 2018-2028 (USD Billion)

75. Middle East Endocrine Testing Market, By End User, 2018-2028 (USD Billion)

76. UAE Endocrine Testing Market, By Test, 2018-2028 (USD Billion)

77. UAE Endocrine Testing Market, By Diagnostic Technology, 2018-2028 (USD Billion)

78. UAE Endocrine Testing Market, By End User, 2018-2028 (USD Billion)

79. South Africa Endocrine Testing Market, By Test, 2018-2028 (USD Billion)

80. South Africa Endocrine Testing Market, By Diagnostic Technology, 2018-2028 (USD Billion)

81. South Africa Endocrine Testing Market, By End User, 2018-2028 (USD Billion)

List of Figures 

1. Global Endocrine Testing Market Segmentation

2. Endocrine Testing Market: Research Methodology

3. Market Size Estimation Methodology: Bottom-Up Approach

4. Market Size Estimation Methodology: Top-Down Approach

5. Data Triangulation

6. Porter’s Five Forces Analysis 

7. Value Chain Analysis 

8. Global Endocrine Testing Market Attractiveness Analysis By Test

9. Global Endocrine Testing Market Attractiveness Analysis By Diagnostic Technology

10. Global Endocrine Testing Market Attractiveness Analysis By End User

11. Global Endocrine Testing Market Attractiveness Analysis By Region

12. Global Endocrine Testing Market: Dynamics

13. Global Endocrine Testing Market Share By Test(2021 & 2028 )

14. Global Endocrine Testing Market Share by Diagnostic Technology(2021 & 2028 )

15. Global Endocrine Testing Market Share by End User(2021 & 2028 )

16. Global Endocrine Testing Market Share by Regions (2021 & 2028 )

17. Global Endocrine Testing Market Share by Company (2020)

This study forecasts revenue at global, regional, and country levels from 2018 to 2028. The Brainy Insights has segmented the global Endocrine Testing market on the basis of below mentioned segments:

Global Endocrine Testing Market by Test:

  • Follicle stimulating hormone(FSH)
  • Human Chorionic Gonadotropin (hCG)
  • Thyroid Stimulating Hormone(TSH)
  • Dehydroepiandrosterone sulfate (DHEAS)
  • Prolactin
  • Progesterone
  • Insulin
  • Cortisol
  • Testosterone
  • Estradiol(E2)
  • Luteinizing Hormone (LH)

Global Endocrine Testing Market by Diagnostic Technology:

  • Immunoassay
  • Clinical Chemistry
  • Monoclonal and Polyclonal Antibody
  • Tandem Mass Spectroscopy

Global Endocrine Testing Market by End User:

  • Hospitals
  • Physicians Offices
  • Health Care Centers
  • Commercial Laboratories

Global Endocrine Testing Market by Region:

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Spain
  • Asia-Pacific
    • Japan
    • China
    • India
  • South America
    • Brazil
  • Middle East and Africa         
    • UAE
    • South Africa

Methodology

Research has its special purpose to undertake marketing efficiently. In this competitive scenario, businesses need information across all industry verticals; the information about customer wants, market demand, competition, industry trends, distribution channels etc. This information needs to be updated regularly because businesses operate in a dynamic environment. Our organization, The Brainy Insights incorporates scientific and systematic research procedures in order to get proper market insights and industry analysis for overall business success. The analysis consists of studying the market from a miniscule level wherein we implement statistical tools which helps us in examining the data with accuracy and precision. 

Our research reports feature both; quantitative and qualitative aspects for any market. Qualitative information for any market research process are fundamental because they reveal the customer needs and wants, usage and consumption for any product/service related to a specific industry. This in turn aids the marketers/investors in knowing certain perceptions of the customers. Qualitative research can enlighten about the different product concepts and designs along with unique service offering that in turn, helps define marketing problems and generate opportunities. On the other hand, quantitative research engages with the data collection process through interviews, e-mail interactions, surveys and pilot studies. Quantitative aspects for the market research are useful to validate the hypotheses generated during qualitative research method, explore empirical patterns in the data with the help of statistical tools, and finally make the market estimations.

The Brainy Insights offers comprehensive research and analysis, based on a wide assortment of factual insights gained through interviews with CXOs and global experts and secondary data from reliable sources. Our analysts and industry specialist assume vital roles in building up statistical tools and analysis models, which are used to analyse the data and arrive at accurate insights with exceedingly informative research discoveries. The data provided by our organization have proven precious to a diverse range of companies, facilitating them to address issues such as determining which products/services are the most appealing, whether or not customers use the product in the manner anticipated, the purchasing intentions of the market and many others.

Our research methodology encompasses an idyllic combination of primary and secondary initiatives. Key phases involved in this process are listed below:

MARKET RESEARCH PROCESS

Data Procurement:

The phase involves the gathering and collecting of market data and its related information with the help of different sources & research procedures.

The data procurement stage involves in data gathering and collecting through various data sources.

This stage involves in extensive research. These data sources includes:

Purchased Database: Purchased databases play a crucial role in estimating the market sizes irrespective of the domain. Our purchased database includes:

  • The organizational databases such as D&B Hoovers, and Bloomberg that helps us to identify the competitive scenario of the key market players/organizations along with the financial information.
  • Industry/Market databases such as Statista, and Factiva provides market/industry insights and deduce certain formulations. 
  • We also have contractual agreements with various reputed data providers and third party vendors who provide information which are not limited to:
    • Import & Export Data
    • Business Trade Information
    • Usage rates of a particular product/service on certain demographics mainly focusing on the unmet prerequisites

Primary Research: The Brainy Insights interacts with leading companies and experts of the concerned domain to develop the analyst team’s market understanding and expertise. It improves and substantiates every single data presented in the market reports. Primary research mainly involves in telephonic interviews, E-mail interactions and face-to-face interviews with the raw material providers, manufacturers/producers, distributors, & independent consultants. The interviews that we conduct provides valuable data on market size and industry growth trends prevailing in the market. Our organization also conducts surveys with the various industry experts in order to gain overall insights of the industry/market. For instance, in healthcare industry we conduct surveys with the pharmacists, doctors, surgeons and nurses in order to gain insights and key information of a medical product/device/equipment which the customers are going to usage. Surveys are conducted in the form of questionnaire designed by our own analyst team. Surveys plays an important role in primary research because surveys helps us to identify the key target audiences of the market. Additionally, surveys helps to identify the key target audience engaged with the market. Our survey team conducts the survey by targeting the key audience, thus gaining insights from them. Based on the perspectives of the customers, this information is utilized to formulate market strategies. Moreover, market surveys helps us to understand the current competitive situation of the industry. To be precise, our survey process typically involve with the 360 analysis of the market. This analytical process begins by identifying the prospective customers for a product or service related to the market/industry to obtain data on how a product/service could fit into customers’ lives.

Secondary Research: The secondary data sources includes information published by the on-profit organizations such as World bank, WHO, company fillings, investor presentations, annual reports, national government documents, statistical databases, blogs, articles, white papers and others. From the annual report, we analyse a company’s revenue to understand the key segment and market share of that organization in a particular region. We analyse the company websites and adopt the product mapping technique which is important for deriving the segment revenue. In the product mapping method, we select and categorize the products offered by the companies catering to domain specific market, deduce the product revenue for each of the companies so as to get overall estimation of the market size. We also source data and analyses trends based on information received from supply side and demand side intermediaries in the value chain. The supply side denotes the data gathered from supplier, distributor, wholesaler and the demand side illustrates the data gathered from the end customers for respective market domain.

The supply side for a domain specific market is analysed by:

  • Estimating and projecting penetration rates through analysing product attributes, availability of internal and external substitutes, followed by pricing analysis of the product.
  • Experiential assessment of year-on-year sales of the product by conducting interviews.

The demand side for the market is estimated through:

  • Evaluating the penetration level and usage rates of the product.
  • Referring to the historical data to determine the growth rate and evaluate the industry trends

In-house Library: Apart from these third-party sources, we have our in-house library of qualitative and quantitative information. Our in-house database includes market data for various industry and domains. These data are updated on regular basis as per the changing market scenario. Our library includes, historic databases, internal audit reports and archives.

Sometimes there are instances where there is no metadata or raw data available for any domain specific market. For those cases, we use our expertise to forecast and estimate the market size in order to generate comprehensive data sets. Our analyst team adopt a robust research technique in order to produce the estimates:

  • Applying demographic along with psychographic segmentation for market evaluation
  • Determining the Micro and Macro-economic indicators for each region 
  • Examining the industry indicators prevailing in the market. 

Data Synthesis: This stage involves the analysis & mapping of all the information obtained from the previous step. It also involves in scrutinizing the data for any discrepancy observed while data gathering related to the market. The data is collected with consideration to the heterogeneity of sources. Robust scientific techniques are in place for synthesizing disparate data sets and provide the essential contextual information that can orient market strategies. The Brainy Insights has extensive experience in data synthesis where the data passes through various stages:

  • Data Screening: Data screening is the process of scrutinising data/information collected from primary research for errors and amending those collected data before data integration method. The screening involves in examining raw data, identifying errors and dealing with missing data. The purpose of the data screening is to ensure data is correctly entered or not. The Brainy Insights employs objective and systematic data screening grades involving repeated cycles of quality checks, screening and suspect analysis.
  • Data Integration: Integrating multiple data streams is necessary to produce research studies that provide in-depth picture to the clients. These data streams come from multiple research studies and our in house database. After screening of the data, our analysts conduct creative integration of data sets, optimizing connections between integrated surveys and syndicated data sources. There are mainly 2 research approaches that we follow in order to integrate our data; top down approach and bottom up approach.

Market Deduction & Formulation: The final stage comprises of assigning data points at appropriate market spaces so as to deduce feasible conclusions. Analyst perspective & subject matter expert based holistic form of market sizing coupled with industry analysis also plays a crucial role in this stage.

This stage involves in finalization of the market size and numbers that we have collected from data integration step. With data interpolation, it is made sure that there is no gap in the market data. Successful trend analysis is done by our analysts using extrapolation techniques, which provide the best possible forecasts for the market.

Data Validation & Market Feedback: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helps us finalize data-points to be used for final calculations.

The Brainy Insights interacts with leading companies and experts of the concerned domain to develop the analyst team’s market understanding and expertise. It improves and substantiates every single data presented in the market reports. The data validation interview and discussion panels are typically composed of the most experienced industry members. The participants include, however, are not limited to:

  • CXOs and VPs of leading companies’ specific to sector
  • Purchasing managers, technical personnel, end-users
  • Key opinion leaders such as investment bankers, and industry consultants

Moreover, we always validate our data and findings through primary respondents from all the major regions we are working on.

Ask for customization Request Sample Speak to analyst Inquire before buying

Flexible Purchase Options

  • Chapters of your choice
  • Quantitative Information for Historical & Forecasted Data
  • Regional/Country Level Reports
Request for Special Pricing

Get in touch with us

+1-315-215-1633

sales@thebrainyinsights.com

Our Clients

Why choose us

ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems

Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system

Global Outreach6 Major regions and 40+ countries level analysis accomplished

Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery

Some Facts About The Brainy Insights

50%

Free Customization

300+

Fortune 500 Clients

1

Free Yearly Update On Purchase Of Multi/Corporate License

900+

Companies Served Till Date